dry eye syndrome
Information
- Disease name
- dry eye syndrome
- Disease ID
- DOID:10140
- Description
- "A lacrimal apparatus disease that is characterized by persistent irritation or burning of the coreneal surface." [url:https\://pubmed.ncbi.nlm.nih.gov/29498987/]
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
| NCT ID | Status | Phase | Summary | Start date | Completion date |
|---|---|---|---|---|---|
| NCT01579539 | Completed | Phase 3 | The Effect of Intravenous Glucocorticoids on the Tearfilm in Eyes With Thyroid-associated Ophthalmopathy | June 27, 2013 | May 18, 2017 |
| NCT02974907 | Completed | Phase 3 | Assessment of the Safety and Efficacy of RGN-259 Ophthalmic Solutions for Dry Eye Syndrome : ARISE-2 | November 2016 | March 2018 |
| NCT03066219 | Completed | Phase 2 | Safety and Efficacy of BRM421 for Dry Eye Syndrome | February 7, 2017 | June 28, 2017 |
| NCT03074344 | Completed | N/A | Cross-linked Hyaluronic Acid and Coenzyme Q10 in the Treatment of Dry Eye | May 2016 | November 2016 |
| NCT03085290 | Completed | N/A | Allogeneic Versus Autologous Serum Eye Drops | June 26, 2017 | October 8, 2018 |
| NCT03088605 | Completed | Phase 2 | Safety and Efficacy of TOP1630 for Dry Eye Syndrome | February 20, 2017 | June 15, 2017 |
| NCT03223909 | Completed | Phase 4 | Efficacy and Safety of the Ophthalmic Solution PRO-087 Versus Systane ® Ultra and Ultra Preservative Free (087LATAMFIV) | October 13, 2016 | December 16, 2018 |
| NCT03364322 | Completed | Influencing Factors on Dry Eye Syndrome and Ocular Surface Disease | June 1, 2016 | June 30, 2017 | |
| NCT03396913 | Completed | N/A | Effectiveness of Intense Pulsed Light for Improving Dry Eye Syndrome | January 10, 2018 | August 15, 2019 |
| NCT03404115 | Completed | Phase 2 | A Multi-Center, Randomized, Double Masked, Parallel-Group, Vehicle-Controlled, Clinical Study to Assess the Safety and Efficacy of Reproxalap Ophthalmic Solution in Subjects With Dry Eye Disease | January 2, 2018 | July 11, 2018 |
| NCT03461575 | Completed | Phase 3 | Efficacy and Safety of HU007 Eye Drops in Patients With Dry Eye Syndrome | January 22, 2018 | July 12, 2018 |
| NCT03569202 | Completed | N/A | Piiloset Trehalose Emulsion Eye Drop Study in Moderate or Severe Dry Eye | May 21, 2018 | November 8, 2018 |
| NCT03576300 | Completed | Comparison of Ocular Surface Features in Patients With Diabetes and Dry Eye Syndrome | February 1, 2018 | August 1, 2018 | |
| NCT03622619 | Completed | N/A | The Effect of Manuka Eye Drops on Tear Film Properties | August 13, 2018 | October 30, 2018 |
| NCT03666884 | Completed | Phase 4 | The Comparison of 50% AS Versus PFAT+ 0.05 % COE in Severe Dry Eye Syndrome | October 10, 2015 | October 25, 2016 |
| NCT03723798 | Completed | Phase 2 | Clinical Study to Investigate the Efficacy and Safety of Orally Administered SA001 in Patients With Dry Eye Syndrome. | November 8, 2017 | October 8, 2018 |
| NCT03764735 | Completed | Phase 3 | Study of SkQ1 as Treatment for Dry-eye Syndrome | December 6, 2018 | February 9, 2019 |
| NCT03830359 | Completed | N/A | Efficacy, Safety of T2769 in Dry Eye Disease | September 1, 2018 | February 18, 2019 |
| NCT03833388 | Completed | Phase 2/Phase 3 | Study of TOP1630 for Dry Eye Syndrome | February 13, 2019 | May 14, 2019 |
| NCT03923244 | Completed | N/A | Dry Eye Syndrome Description During Cataract Surgery, With Multimodal Analysis of the Ocular Surface | April 1, 2019 | March 6, 2020 |
| NCT03982368 | Completed | Phase 2 | A Study to Evaluate Safety and Efficacy of rhNGF Eye Solution vs Vehicle in Patients With Moderate to Severe Dry Eye | June 10, 2019 | July 15, 2020 |
| NCT04030962 | Completed | Phase 2 | A Study of the Drugs AGN-242428 and AGN-231868 in Participants With Dry Eye Disease | March 4, 2020 | March 18, 2022 |
| NCT04139122 | Completed | Phase 1/Phase 2 | Safety, PK and Efficacy Study of SJP-0132 in Subjects With Dry Eye Disease | October 5, 2019 | March 3, 2020 |
| NCT04147650 | Completed | Phase 2/Phase 3 | Dose Ranging Study to Assess the Efficacy and Safety of Voclosporin Ophthalmic Solution in Subjects With Dry Eye Syndrome | October 14, 2019 | October 8, 2020 |
| NCT04206020 | Completed | Phase 3 | Vehicle-Controlled Study of SkQ1 as Treatment for Dry-eye Syndrome | December 20, 2019 | October 6, 2020 |
| NCT04343287 | Completed | Phase 2/Phase 3 | Safety and Efficacy of BRM421 for Dry Eye Syndrome Treatment | January 15, 2020 | June 23, 2020 |
| NCT04938908 | Completed | Phase 2 | Probiotic in Dry Eye Syndromes | July 1, 2021 | July 30, 2022 |
| NCT05136170 | Completed | Phase 3 | Study to Evaluate Safety and Efficacy of Cenegermin (Oxervate®) vs Vehicle in Severe Sjogren's Dry Eye Disease | January 27, 2022 | May 24, 2023 |
| NCT05656196 | Completed | N/A | VGH-DESJS-1 in Ocular and Oral Dryness Symptoms of Dry Eye Syndrome and Sjögren's Syndrome | April 1, 2023 | December 31, 2023 |
| NCT05878067 | Completed | Phase 3 | A Study to Assess Symptom Relief and Product Tolerability of ABBV-444 Drops in Adult Participants | June 27, 2023 | October 6, 2023 |
| NCT06288945 | Completed | N/A | Effect of an Educational Program on Health-related Outcomes of Patients With Dry Eye Syndrome | January 15, 2023 | September 14, 2023 |
| NCT00442273 | Completed | N/A | Comparison of Autologous Serum and Umbilical Cord Serum Eyedrops for Dry Eye Syndrome | ||
| NCT00514852 | Completed | N/A | Safety and Efficacy of an Artificial Tear for the Treatment of Dry Eye | October 2007 | January 2008 |
| NCT00522600 | Completed | Eye Drop Use in Glaucoma Patients Through Patient Surveys and Video Observations | February 2007 | July 2007 | |
| NCT00535054 | Completed | N/A | Study to Assess the Safety and Patients' Satisfaction of Tears Again* in the Treatment of Dry Eye Symptoms | September 2007 | February 2010 |
| NCT00544713 | Completed | N/A | Evaluate the Safety and Efficacy of a New Artificial Tear for Use After LASIK Surgery | September 2007 | June 2008 |
| NCT00565669 | Completed | N/A | Evaluation of Blink Tears and Systane Concomitant With Restasis for the Treatment of Dry Eye Symptoms | October 2007 | October 2008 |
| NCT00735865 | Completed | N/A | Lid Margin And Conjunctival Microbial Flora Following Punctum Occlusion | July 2003 | May 2009 |
| NCT00765804 | Completed | Phase 2 | Safety and Efficacy Study of Iontophoresis and Dexamethasone Phosphate to Treat Dry Eye | October 2008 | February 2009 |
| NCT00799552 | Completed | Phase 2 | Safety and Efficacy Study of RX-10045 on the Signs and Symptoms of Dry Eye | November 2008 | June 2009 |
| NCT00818909 | Completed | Phase 4 | Systane Clinical Experience Study | January 2009 | October 2009 |
| NCT00893243 | Completed | Efficacy Comparative Study Between Tears Again®, Opticol® and Optive® | |||
| NCT00932477 | Completed | N/A | Safety and Tolerability of Artificial Tears in Dry Eye Subjects | August 2009 | September 2009 |
| NCT00991679 | Completed | CXCL9, CXCL10, CXCL11, and CXCR3 in Dry Eye Syndrome | February 2008 | December 2008 | |
| NCT01010282 | Completed | N/A | Safety and Efficacy of Two Artificial Tears in Dry Eye Subjects | November 2009 | April 2010 |
| NCT01013077 | Completed | N/A | The Effect of a New Emulsion in Dry Eye Patients on Tear Layer Aberrometry, Contrast Sensitivity, and Reading Ability | November 2009 | August 2011 |
| NCT01107964 | Completed | N/A | Oral Omega-3 Fatty Acids in the Treatment of Dry Eye Syndrome | July 2010 | June 15, 2015 |
| NCT01162954 | Completed | Phase 1 | Phase I Study to Evaluate the Tolerability of Eye Drop DA-6034 in Healthy Volunteers | September 2008 | March 2009 |
| NCT01163643 | Completed | Phase 2 | Study to Assess the Safety and Efficacy of BOL-303242-X Ophthalmic Suspension in Dry Eye Syndrome | July 2010 | July 2011 |
| NCT01198782 | Completed | Phase 4 | Evaluating Safety and Efficacy of FID 112903 Post Discontinuation of Long-term Use of RESTASIS® (Cyclosporine Ophthalmic Emulsion) 0.05% | September 2010 | May 2011 |
| NCT01212471 | Completed | Phase 3 | A Dose Ranging Study to Evaluate Safety and Efficacy of Bromfenac Ophthalmic Solution in Dry Eye Disease | September 2010 | December 2011 |
| NCT01223040 | Completed | N/A | An Open-Label, Single-Center Study Evaluating the Effect of Systane Balance on Video Ocular Protection Index (OPI) and Blink Patterns in Patients Diagnosed With Dry Eye | August 2010 | |
| NCT01252121 | Completed | N/A | Residence Time Evaluation of Systane Ultra Lubricant Eye Drops vs. Hialid and Saline | October 2010 | June 2011 |
| NCT01339936 | Completed | Phase 2/Phase 3 | Evaluation of the Effect of Repeated Usage on the Tear Film Characteristics of an Investigational Eye Drop in Dry Eye Sufferers | March 2011 | May 2012 |
| NCT01382225 | Completed | Phase 3 | Sodium Hyaluronate Ophthalmic Solution, 0.18% for Treatment of Dry Eye Syndrome | July 2011 | May 2012 |
| NCT01387347 | Completed | Phase 2 | Safety and Efficacy of Thymosin Beta 4 Ophthalmic Solution in Patients With Dry Eye | August 2011 | December 2011 |
| NCT01483989 | Completed | N/A | In Vivo Measurement of Corneal Epithelial Changes in Dry Eye Patients | February 2011 | June 2011 |
| NCT01541891 | Completed | Phase 2 | Efficacy and Safety of PRO-148 Ophthalmic Solution Versus SYSTANE® in the Treatment of Patients With Dry Eye Syndrome | October 2011 | May 2012 |
| NCT00344721 | Completed | N/A | A Placebo Controlled Double Masked Clinical Assessment Study of Essential Fatty Acid Supplement and Its Effect on Patients With Apparent Aqueous Deficient Dry Eye Syndrome | September 2004 | October 2008 |
| NCT01614600 | Completed | N/A | Clinical Evaluation of a Daily Disposable Contact Lens in Symptomatic Weekly/Monthly Lens Wearers | June 2012 | September 2012 |
| NCT01632137 | Completed | Phase 3 | Efficacy and Safety of Rebamipide in Subjects With Dry Eye Syndrome | June 2012 | |
| NCT01670357 | Completed | Phase 2 | Phase II Study of DA-6034 Eye Drops in Dry Eye Syndrome | April 2012 | March 2013 |
| NCT01675570 | Completed | Phase 2 | A Study of RX-10045 in the Treatment of Dry Eye Disease | August 2012 | November 2012 |
| NCT01688726 | Completed | N/A | Evaluation of SYSTANE® BALANCE in Dry Eye Subjects With Lipid Deficiency | December 2012 | November 2013 |
| NCT01733732 | Completed | N/A | SYSTANE® BALANCE Symptoms (OSDI) & Inflammatory Biomarkers | March 2013 | October 2013 |
| NCT01733745 | Completed | N/A | SYSTANE® Family - Meibomian Deficiency | February 2013 | June 2013 |
| NCT01744457 | Completed | N/A | Reproducibility of Tearfilm Osmolarity Measurements Using TearLab® in Patients With Dry Eye Syndrome and Healthy Subjects | February 2011 | June 2012 |
| NCT01745887 | Completed | Phase 1 | A Multi-Center Study Subjects With Dry Eye Syndrome | November 2012 | November 2012 |
| NCT01747616 | Completed | Phase 1 | Assessment of Safety and Tolerability of Chitosan-N-acetylcysteine Eye Drops in Subjects While Wearing Contact Lenses and Before Insertion of Contact Lenses | July 2011 | December 2012 |
| NCT01753687 | Completed | N/A | Correlation of Different Signs for Assessment of Dry Eye Syndrome | September 2011 | September 2013 |
| NCT01753752 | Completed | Phase 2 | Evaluation of the Corneal Residence Time of Chitosan-N-acetylcysteine Eye Drops in Patients With Dry Eye Syndrome After Single and Multiple Instillation | September 2012 | March 2013 |
| NCT01776658 | Completed | Phase 1/Phase 2 | Pilot Study to Evaluate SYL1001 Safety and Effect in Patients With Ocular Pain | November 2012 | |
| NCT01797822 | Completed | Phase 4 | Effects of Dry Eye Treatments on the Ocular Surface | February 2013 | December 2015 |
| NCT01808560 | Completed | N/A | Treatment of Meibomian Gland Dysfunction Prior to Cataract Surgery | March 2013 | January 2015 |
| NCT01850979 | Completed | Phase 4 | Treatment of Dry Eye Using 0.03% Tacrolimus Eye Drops | February 2010 | November 2011 |
| NCT01863368 | Completed | N/A | Clinical Evaluation of Systane® ULTRA Compared to OPTIVE® in Ocular Surface Staining | September 2013 | June 2014 |
| NCT01864330 | Completed | Phase 4 | Influence of Lachrymal Substitutes on Tear Film Thickness in Patients With Moderate Dry Eye Syndrome | May 2013 | September 2013 |
| NCT01942226 | Completed | Investigation on Medical Management of Dry Eye Patients | August 2013 | December 2013 | |
| NCT01970917 | Completed | Phase 4 | Effect of Olixia Pure® Eye Drops on Tear Film Thickness in Healthy Subjects | October 2013 | November 2013 |
| NCT02023268 | Completed | Phase 3 | Efficacy and Safety of T2762 and Vismed® in Dry Eye Syndrome | December 2013 | February 2015 |
| NCT02066051 | Completed | N/A | IPL and Meibomian Gland Expression to Treat Ocular Rosacea Ocular GVHD | October 2013 | November 2014 |
| NCT02078661 | Completed | Phase 1/Phase 2 | Safety and Efficacy of PG101 for Dry Eye Syndrome | December 2013 | January 2014 |
| NCT02092207 | Completed | Phase 2 | Phase 2 Study to Evaluation the Safety and Efficacy of Orally Administered KL7016 in Patients With Dry Eye Syndrome | October 2012 | July 2014 |
| NCT02100787 | Completed | N/A | Changes in Tear Osmolarity Over Time With Sustained Use of TheraTears | April 10, 2014 | June 30, 2016 |
| NCT02101281 | Completed | Phase 2 | Safety and Efficacy of rhNGF Eye Drops at Different Doses in Patients With Dry Eye | January 20, 2014 | January 2015 |
| NCT02315079 | Completed | Point of Care Testing of Inflammatory Markers in Tears | January 2015 | January 2017 | |
| NCT02326090 | Completed | Phase 2 | Phase 2 Study With Cis-UCA Ophthalmic Solutions in Subjects With Dry Eye | December 2014 | April 2015 |
| NCT02369861 | Completed | Phase 1 | Study of ST266 Eye Drops in Treating Dry Eye | March 2015 | December 2015 |
| NCT02376556 | Completed | The Effect of Eyelid Surgery on Dry Eye - a Prospective Study | March 2015 | March 2018 | |
| NCT02446015 | Completed | N/A | Clinical Evaluation Following Use of SYSTANE® ULTRA in the Management of Dry Eye | June 19, 2015 | June 21, 2016 |
| NCT02455999 | Completed | Phase 2 | Dose-finding Study to Assess the Safety and Effect of SYL1001 in Patients With Ocular Pain | June 2015 | |
| NCT02492412 | Completed | Phase 3 | Efficacy and Safety of HE10 for Dry Eye Syndrome | May 2013 | September 2014 |
| NCT02507934 | Completed | N/A | Tolerability, Safety and Efficacy of Lubricin (150 µg/ml) Eye Drops Versus Sodium Hyaluronate (HA) 0.18% Eye Drops in Patients With Moderate Dry Eye (DE) | June 2015 | September 2015 |
| NCT02510235 | Completed | N/A | Tolerability, Safety and Efficacy of Lubricin Eye Drops vs Sodium Hyaluronate Eye Drops in Subjects With Mod. Dry Eye | March 2015 | June 2015 |
| NCT02522312 | Completed | A Retrospective Analysis of Restasis® Benefits in Dry Eye Contact Lens Patients | September 2015 | December 2015 | |
| NCT02597803 | Completed | Phase 2/Phase 3 | Assessment of the Safety and Efficacy of RGN-259 Ophthalmic Solutions for Dry Eye Syndrome: ARISE-1 | September 2015 | July 2016 |
| NCT02645045 | Completed | Evaluation of Factors Affecting the Tear-film Lipid Layer Thickness | December 11, 2015 | February 10, 2016 | |
| NCT02680158 | Completed | N/A | A Study to Evaluate the Safety and Effectiveness of Oculeve Intranasal Lacrimal Neurostimulator in Participants With Dry Eye Syndrome | January 31, 2016 | March 31, 2016 |
| NCT02715323 | Completed | Exploring Immune Cell Signatures in Autoimmunity and Dry Eye Syndrome | May 2016 | November 2019 | |
| NCT02758327 | Completed | Phase 4 | Evaluation of Tear Osmolarity Over Time With Sustained Use of Thera Tears Lubricating Drops | October 2015 | March 2016 |
| NCT02798289 | Completed | N/A | Acute Tear Production Following Single Use of the Oculeve Intranasal Neurostimulator | June 2016 | August 2016 |
| NCT02917512 | Completed | Phase 2 | Efficacy and Safety Study of HU00701/HU007 Eye Drops in Patients With Dry Eye Syndrome | March 2016 | December 2016 |
| NCT02958514 | Completed | N/A | Efficacy Comparison of Two Kinds of Treatment in Treating Dry Eye Caused by Meibomian Gland Dysfunction | November 2016 | March 2017 |
| NCT06240364 | Not yet recruiting | N/A | Effects of AffronEye®/ Crocuvis+® on Dry Eye Syndrome | October 10, 2024 | April 30, 2025 |
| NCT03938207 | Not yet recruiting | Dry Eye Syndrome, Healthy Control, Sjögren's Syndrome and Other Inflammation Disease in Taiwan Biobank | October 1, 2022 | December 31, 2027 | |
| NCT06375499 | Not yet recruiting | N/A | Comparison of the Performance and Safety of T2769 Versus Hylo-Forte® in the Treatment of Moderate to Severe Dry Eye Syndrome. | August 1, 2024 | April 28, 2025 |
| NCT06172530 | Recruiting | Observational Study on the Improvement of Dry Eye Syndrome, Treatment Satisfaction, and Intraocular Tolerance With Diquasol Eye Drops | February 8, 2023 | December 2024 | |
| NCT04747288 | Recruiting | Objective Measurement With TCM Pattern for AIDDES | February 1, 2021 | December 31, 2024 | |
| NCT06190028 | Recruiting | N/A | Evaluation of Performance and Safety of Carbopol 980 NF 0.2%- Based Medical Device in the Management of Patients With Glaucomar or Ocular Hypertension and Concomitant Dry Eye Syndrome on Multiple Long-term Topical Hypotensive Therapy | June 14, 2023 | December 2024 |
| NCT04198740 | Recruiting | Proteomic and Metabolomic Lacrimal Fingerprint in Diverse Pathologies of the Ocular Surface | February 1, 2020 | January 2035 | |
| NCT04877483 | Recruiting | N/A | To Evaluate the Short-term and Long Term Efficacy of Acupuncture in Ocular and Oral Dryness Symptoms of Dry Eye Syndrome | December 6, 2022 | December 31, 2024 |
| NCT02617095 | Terminated | N/A | Comparison of the Efficacy and Safety of T2762 Versus Optive® in the Treatment of Moderate to Severe Dry Eye Syndrome | February 2015 | October 2016 |
| NCT03803722 | Terminated | N/A | To Demonstrate the Non-inferiority of Eyestil Protection® Compared to Vismed® in Terms of Clinical Performance | July 8, 2019 | June 30, 2020 |
| NCT01228929 | Terminated | N/A | Non-invasive Ocular Surface Measurements Before and After Interventions | July 2010 | January 2014 |
| NCT05245604 | Unknown status | Phase 3 | Evaluating the Efficacy and Safety of TJO-087 in Moderate to Severe Dry Eye Disease Patients | June 19, 2020 | April 2023 |
| NCT01561040 | Unknown status | Phase 4 | Oral Nutrition Impact on Tear Film | March 2012 | December 2012 |
| NCT02849093 | Unknown status | Optical Coherence Tomography of Ocular Structures in Epiphora and Dry Eye Syndrome. | June 2016 | December 2017 | |
| NCT03652415 | Unknown status | DRy Eye Outcome and Prescription Study | August 23, 2018 | August 23, 2021 | |
| NCT04711642 | Unknown status | Phase 3 | Comprehensive Study on Dry Eye and Ocular Surface Disease Prior and After Cataract Surgery | January 15, 2021 | July 15, 2023 |
| NCT03162094 | Unknown status | Phase 1/Phase 2 | Assessing the Safety and Efficacy of AVX-012 in Subjects With Mild-to-moderate Dry Eye Syndrome | April 3, 2017 | December 2018 |
| NCT03403023 | Unknown status | N/A | Corneal Tear Film Imaging of the Cornea Before and After Restasis Therapy | January 30, 2018 | December 30, 2018 |
| NCT04884217 | Unknown status | Phase 2 | Treatment of Dry Eye Disease Using Pro-ocular™ - A Proof of Concept, Safety, and Efficacy Study | May 20, 2021 | December 30, 2021 |
| NCT04025801 | Unknown status | Heidelberg In Vivo Confocal Microscopy to Evaluate the Ocular Surface Disorders of Healthy and Diseased Individuals | July 31, 2019 | June 2020 | |
| NCT03464357 | Unknown status | N/A | Functional MRI Study of Cortical Modifications to Light Stimulation in Patients With Photophobia | March 13, 2018 | March 2019 |
| NCT03539159 | Unknown status | N/A | Assessment of the Mu-Drop System for Serum Eye Drops | December 6, 2018 | February 1, 2020 |
| NCT02774707 | Unknown status | Comparing the Quality of Topical Autologous Serum in Different Etiologies of Dry Eye Syndrome | January 2016 | January 2017 | |
| NCT02777723 | Unknown status | Phase 3 | Study to Evaluate the Efficacy and Safety of CKD-350 | May 2016 | September 2016 |
| NCT01917539 | Withdrawn | N/A | Efficacy of Pulsed Light Therapy for Meibomian Gland Dysfunction and Dry Eye Syndrome | June 2013 | May 2015 |
| NCT00812721 | Withdrawn | N/A | Tears Substitutions and Their Effects on Higher Order Aberrometery | January 2009 | July 2009 |
| NCT01957670 | Withdrawn | N/A | Pilot Study to Clinical Evaluate Device Prototypes in Dry Eye Patients | February 2014 | April 2016 |
| NCT00355459 | Withdrawn | N/A | A Prospective Clinical Study Assessing the Effects of Tetracycline Antibiotic on Tear Film and Tear Lipid Composition Within a Population of Patients Diagnosed With Blepharitis and Dry Eye Disease | August 2005 | April 2007 |
| NCT01753596 | Withdrawn | Phase 3 | Assessment of Tear Film Thickness by Optical Coherence Tomography in Healthy Subjects and Subjects With Dry Eye Disease | December 2014 | February 2015 |
| NCT03937271 | Withdrawn | Objective Measurement Methods for Autoimmune Disease and Dry Eye Syndrome | April 1, 2019 | December 31, 2020 |
- Disase is a (Disease Ontology)
- DOID:1400
- Cross Reference ID (Disease Ontology)
- ICD10CM:H04.12
- Cross Reference ID (Disease Ontology)
- MESH:D015352
- Cross Reference ID (Disease Ontology)
- NCI:C34553
- Cross Reference ID (Disease Ontology)
- SNOMEDCT_US_2023_03_01:193980001
- Cross Reference ID (Disease Ontology)
- UMLS_CUI:C0013238
- Exact Synonym (Disease Ontology)
- dry eye disease
- Exact Synonym (Disease Ontology)
- Tear film insufficiency
- MedGen concept unique identifier (MedGen Concept name)
- C0013238
- MedGen unique identifier (MedGen Concept name)
- 4411